Difference between revisions of "Editorial Board"
Jump to navigation
Jump to search
(Created page with "This page is the future home of our editorial board...stay tuned! =Editor-in-Chief= Peter C. Yang MD, Attending Physician at Massachusetts General Hospital...") |
Warner-admin (talk | contribs) |
||
Line 1: | Line 1: | ||
− | + | Please feel free to contact us with any questions or inquiries, at the email addresses below. | |
=Editor-in-Chief= | =Editor-in-Chief= | ||
− | [[User:PeterYang|Peter C. Yang MD]], | + | <big>[[User:PeterYang|Peter C. Yang, MD]], Boston, MA</big> |
+ | <br>[mailto:[email protected] [email protected]] | ||
+ | <br>Twitter: [https://twitter.com/Hem_Onc Hem_Onc] | ||
=Deputy Editor= | =Deputy Editor= | ||
− | [[User:Jwarner|Jeremy L. Warner MD, MS]], | + | {| border="1" style="text-align:center;" |
+ | |- | ||
+ | |[[File:Warner Jeremy2 compact.jpg|thumb|upright=0.4|center]] | ||
+ | |<big>[[User:Jwarner|Jeremy L. Warner, MD, MS]]<br>Nashville, TN</big><br>[mailto:[email protected] [email protected]]<br>Twitter: [https://twitter.com/Hemoncwarner Hemoncwarner]<br>[https://www.linkedin.com/in/jeremy-warner-39001512/ LinkedIn] | ||
+ | |- | ||
+ | |} | ||
− | =Section Editors, Oncology= | + | =Section Editors= |
− | Coming soon | + | {| border="1" style="text-align:center;" |
− | + | !colspan="3" align="center" style="color:white; font-size:125%; background-color:#00008B"|'''Dermatologic Oncology''' | |
− | = | + | |- |
− | Coming soon | + | |rowspan=4|[[File:Bethbuchbinder.jpg|thumb|upright=0.4|center]] |
+ | |rowspan=4|<big>[[User:Bethbuchbinder|Elizabeth Buchbinder, MD]]<br>Boston, MA</big><br>[https://www.linkedin.com/in/beth-buchbinder-2a9b994/ LinkedIn] | ||
+ | |[[Melanoma]] | ||
+ | |- | ||
+ | |[[Merkel cell carcinoma]] | ||
+ | |- | ||
+ | |[[Basal cell and squamous cell skin cancer]] | ||
+ | |- | ||
+ | |[[Cutaneous T-cell lymphoma]] | ||
+ | |- | ||
+ | !colspan="3" align="center" style="color:white; font-size:125%; background-color:#00008B"|'''Genitourinary Oncology''' | ||
+ | |- | ||
+ | |rowspan=5|Coming soon | ||
+ | |rowspan=5|<big>Aymen Elfiky, MD, MSc, MBA<br>Boston, MA</big><br>[https://www.linkedin.com/in/aymen-elfiky-15420873/ LinkedIn] | ||
+ | |[[Bladder cancer]] | ||
+ | |- | ||
+ | |[[Penile cancer]] | ||
+ | |- | ||
+ | |[[Prostate cancer]] | ||
+ | |- | ||
+ | |[[Renal cancer]] | ||
+ | |- | ||
+ | |[[Testicular cancer]] | ||
+ | |- | ||
+ | !colspan="3" align="center" style="color:white; font-size:125%; background-color:#00008B"|'''Gynecologic Oncology''' | ||
+ | |- | ||
+ | |rowspan=4|[[File:BrandonSeagle.jpg|thumb|upright=0.4|center]] | ||
+ | |rowspan=4|<big>[[User:Blseagle|Brandon L. Seagle, MD, MS]]<br>Chicago, IL</big> | ||
+ | |[[Cervical cancer]] | ||
+ | |- | ||
+ | |[[Germ cell tumors]] | ||
+ | |- | ||
+ | |[[Ovarian cancer]] | ||
+ | |- | ||
+ | |[[Uterine cancer]] | ||
+ | |- | ||
+ | !colspan="3" align="center" style="color:white; font-size:125%; background-color:#00008B"|'''Neuro-Oncology''' | ||
+ | |- | ||
+ | |rowspan=4|[[File:SeemaNagpal.jpg|thumb|upright=0.4|center]] | ||
+ | |rowspan=4|<big>[[User:Seemanagpal|Seema Nagpal, MD]]<br>Palo Alto, CA</big> | ||
+ | |[[Central nervous system (CNS) cancer]] | ||
+ | |- | ||
+ | |[[CNS leukemia]] | ||
+ | |- | ||
+ | |[[CNS lymphoma]] | ||
+ | |- | ||
+ | |[[Glioblastoma]] | ||
+ | |- | ||
+ | !colspan="3" align="center" style="color:white; font-size:125%; background-color:#00008B"|'''Sarcoma''' | ||
+ | |- | ||
+ | |rowspan=4|Coming soon | ||
+ | |rowspan=4|<big>James L. Chen, MD, MS<br>Columbus, OH</big><br>[https://www.linkedin.com/in/jameschen777/ LinkedIn] | ||
+ | |[[Ewing's sarcoma]] | ||
+ | |- | ||
+ | |[[Gastrointestinal stromal tumor]] | ||
+ | |- | ||
+ | |[[Osteosarcoma]] | ||
+ | |- | ||
+ | |[[Sarcoma|Sarcoma (other types)]] | ||
+ | |- | ||
+ | !colspan="3" align="center" style="color:white; font-size:125%; background-color:#00008B"|'''Thoracic Oncology''' | ||
+ | |- | ||
+ | |rowspan=5|[[File:TravisOsterman.jpg|thumb|upright=0.4|center]] | ||
+ | |rowspan=5|<big>[[User:Travisosterman|Travis Osterman, DO, MS]]<br>Nashville, TN</big><br>Twitter: [https://twitter.com/TravisOsterman TravisOsterman]<br>[https://www.linkedin.com/in/travis-osterman-1850b236/ LinkedIn] | ||
+ | |[[Esophageal cancer]] | ||
+ | |- | ||
+ | |[[Mesothelioma]] | ||
+ | |- | ||
+ | |[[Non-small cell lung cancer]] | ||
+ | |- | ||
+ | |[[Small cell lung cancer]] | ||
+ | |- | ||
+ | |[[Thymoma]] | ||
+ | |- | ||
+ | !colspan="3" align="center" style="color:white; font-size:125%; background-color:#FF0D00"|'''Myeloproliferative Neoplasms''' | ||
+ | |- | ||
+ | |rowspan=7|Coming soon | ||
+ | |rowspan=7|<big>Sanjay R. Mohan, MD, MSCI<br>Nashville, TN</big> | ||
+ | |[[Chronic myelogenous leukemia]] | ||
+ | |- | ||
+ | |[[Chronic myelomonocytic leukemia]] | ||
+ | |- | ||
+ | |[[Essential thrombocythemia]] | ||
+ | |- | ||
+ | |[[Hypereosinophilic syndrome]] | ||
+ | |- | ||
+ | |[[Myelofibrosis]] | ||
+ | |- | ||
+ | |[[Polycythemia vera]] | ||
+ | |- | ||
+ | |[[Systemic mastocytosis]] | ||
+ | |- | ||
+ | !colspan="3" align="center" style="color:white; font-size:125%; background-color:#FF0D00"|'''Plasma Cell Dyscrasias''' | ||
+ | |- | ||
+ | |rowspan=3|[[File:Headshot Cowan.jpg|thumb|upright=0.4|center]] | ||
+ | |rowspan=3|<big>[[User:Andrewc072|Andrew J. Cowan, MD]]<br>Seattle, WA</big><br>[https://www.linkedin.com/in/andrew-cowan-63b3a130/ LinkedIn] | ||
+ | |[[Multiple myeloma]] | ||
+ | |- | ||
+ | |[[Light-chain (AL) amyloidosis]] | ||
+ | |- | ||
+ | |[[Plasma cell leukemia]] | ||
+ | |- | ||
+ | |} |
Revision as of 01:04, 29 September 2017
Please feel free to contact us with any questions or inquiries, at the email addresses below.
Editor-in-Chief
Peter C. Yang, MD, Boston, MA
[email protected]
Twitter: Hem_Onc
Deputy Editor
Jeremy L. Warner, MD, MS Nashville, TN [email protected] Twitter: Hemoncwarner |